BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15150597)

  • 1. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence.
    Zappa M; Visioli CB; Ciatto S; Iossa A; Paci E; Sasieni P
    Br J Cancer; 2004 May; 90(9):1784-6. PubMed ID: 15150597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
    Crocetti E; Battisti L; Betta A; Palma PD; Paci E; Piffer S; Pojer A; Polla E; Zappa M
    Eur J Cancer Prev; 2007 Dec; 16(6):564-7. PubMed ID: 18090131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan.
    Makino H; Sato S; Yajima A; Komatsu S; Fukao A
    Tohoku J Exp Med; 1995 Mar; 175(3):171-8. PubMed ID: 7792786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
    Castanon A; Landy R; Sasieni PD
    Int J Cancer; 2016 Sep; 139(5):1040-5. PubMed ID: 27096255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practical points of reference for the prevention and early detection of cervical cancer].
    Ebeling K
    Z Arztl Fortbild (Jena); 1986; 80(7):306-10. PubMed ID: 3727623
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytological screening history of patients with early invasive cervical cancer.
    Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
    Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The screening history of women with cervical cancer in the Rotterdam area.
    Kreuger FA; Beerman H
    Eur J Epidemiol; 2000; 16(7):641-5. PubMed ID: 11078121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
    Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
    Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection against squamous cell carcinoma and cervical adenocarcinoma afforded by cervical cytology screening: a cross-sectional study.
    Vale DB; Braganca JF; Morais SS; Zeferino LC
    Int J Gynecol Cancer; 2014 Feb; 24(2):321-8. PubMed ID: 24407579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in cancer of the cervix uteri in Sweden following cytological screening.
    Bergström R; Sparén P; Adami HO
    Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening: patients understanding in major hospitals in Malaysia.
    Othman NH; Devi BC; Halimah Y
    Asian Pac J Cancer Prev; 2009; 10(4):569-74. PubMed ID: 19827871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and adenocarcinoma of the cervix.
    Sasieni P; Castanon A; Cuzick J
    Int J Cancer; 2009 Aug; 125(3):525-9. PubMed ID: 19449379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does screening by "Pap" smears help prevent cervical cancer? A case-control study.
    Clarke EA; Anderson TW
    Lancet; 1979 Jul; 2(8132):1-4. PubMed ID: 87887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study.
    Mitchell H; Hocking J; Saville M
    Acta Cytol; 2004; 48(5):595-600. PubMed ID: 15471249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.